Related Experiment Video
Updated: Jul 14, 2026

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
Published on: March 16, 2022
TLR2 activation by proteosomes promotes uptake of particulate vaccines at mucosal surfaces
Sophie M Chabot1, Tyler S Chernin, May Shawi
1Harvard Medical School, Department of Pediatrics, GI Cell Biology Laboratory, Children's Hospital Boston and Harvard Digestive Diseases Center, 300 Longwood Avenue, Boston, MA 02115, USA. sophie.chabot@childrens.harvard.edu
Abstract:
Proteosome-based vaccines have TLR2-based adjuvant activity and show promise for mucosal immunization. We examined the effects of proteosomes on mucosal uptake in Peyer's patches in vivo. Proteosomes accelerated transepithelial transport of microparticles by M cells and induced migration of dendritic cells (DCs) into the follicle-associated epithelium (FAE); both effects were dependent on TLR2. Proteosomes induced the release of the DC-attracting chemokine MIP3alpha from Caco-2 epithelial cells in vitro. In HEK cells, proteosome-mediated MIP3alpha release was dependent on TLR2 expression and matrix metalloproteinase activation. Thus, TLR2 activation by proteosomes may promote mucosal uptake of particulate vaccines, and this may contribute to their adjuvanticity.
Related Concept Videos
Vaccinations
Antigen Processing Pathways
MHC Class I: Presenting Endogenous...
Receptor-mediated Endocytosis
Receptor-mediated Endocytosis
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Protein Transport to the Thylakoids
Vaccines

